How far are we from an approved drug for nonalcoholic steatohepatitis?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

How far are we from an approved drug for nonalcoholic steatohepatitis?

Published:2023-05-01 Issue:9 Volume:24 Page:1021-1038
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Méndez-Sánchez Nahum¹²,Pal Shreya C.²,Córdova-Gallardo Jacqueline²³

Affiliation:

1. Liver Research Unit, Medica Sur Clinic & Foundation, Mexico City, Mexico

2. Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico

3. Department of Hepatology, Service of Surgery, General Hospital “Dr. Manuel Gea González”, Mexico City, Mexico

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2023.2206953

Reference134 articles.

1. Nonalcoholic steatohepatitis is the most common indication for liver transplantation among the elderly: Data from the United States Scientific Registry of Transplant Recipients

2. Global multi-stakeholder endorsement of the MAFLD definition

3. Review article: the emerging role of genetics in precision medicine for patients with non-alcoholic steatohepatitis

4. New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis

5. Non-alcoholic fatty liver disease

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug targets regulate systemic metabolism and provide new horizons to treat nonalcoholic steatohepatitis;Metabolism Open;2024-03

2. AdipoRon and ADP355, adiponectin receptor agonists, in Metabolic-associated Fatty Liver Disease (MAFLD) and Nonalcoholic Steatohepatitis (NASH): A systematic review;Biochemical Pharmacology;2023-12

3. Molecular Mechanisms Involved in MAFLD in Cholecystectomized Patients: A Cohort Study;Genes;2023-10-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3